successful-doctor

CARETEQ BRANDS

HMR Referrals matches GPs with Accredited Pharmacists to provide continuity of care and improve clinical outcomes for patients by conducting Home Medication Reviews (HMRs).

Medication-related harm is a critical issue in healthcare, encompassing adverse drug reactions, medication errors, and complications that jeopardise patient safety and lead to increased healthcare costs.

1 in 2 People aged 65+ taking 5+ medications

88% Likelihood of an adverse drug reaction if taking 5+ medications

66% Reduction in falls risk when removing high-risk medications

HMRs conducted by pharmacists can reduce medication-related problems and improve adherence. HMRs are also associated with a reduction in hospitalisation rates for older people living in the community. HMR Referrals is a SaaS platform bringing GPs and Accredited Pharmacists together to improve clinical outcomes for the patient, whilst also increasing clinic revenue.

Visit HMR Referrals website
EHS_Logo_Colour

Embedded Health Solutions (EHS) is Australia’s most trusted partner of medication management and home care solutions.

As leaders in medication management, Ward Medication Management and Mederev have joined forces to form EHS. EHS brings innovative and comprehensive solutions to improve the way Quality Use of Medicine and medication management is delivered in Aged Care.

EHS helps health care workers with professional knowledge and advice to help prevent incidents of medicine-related harm and to ensure that residents and patients get the best out of life. EHS provides expert geriatric clinical pharmacy decision support to GPs, delivers medication training to health professionals and provides individuals with a proactive medication service.

VISIT EHS WEBSITE
Latest From Our Blog

News and Updates

CTQ Q1FY26 Activities Report and Appendix 4C

Careteq Limited (ASX: CTQ) (“Careteq” or “the Company”), a clinical healthtech company specialising in innovative medication management and clinical governance solutions, is pleased to provide the following quarterly update and commentary on its Appendix 4C [...]

CTQ FY25 Preliminary Full Year Results

Careteq is pleased to release its unaudited preliminary full year results for the period ended 30 June 2025 (“FY25”): Revenue up 5.4% and Group EBITDA up 171% from Continuing Operations

CTQ Q4-FY25 Activities Report & Appendix 4C

Careteq is pleased to release its Q4 FY25 Activities Report and Appendix 4C: Platform Integration Nears Completion, Revenue Growth Exceeds Projections, and Strategic Partnerships Expand

Careteq’s Q3 FY25 Activities Report And Appendix 4C

Careteq is pleased to release its Q3 FY25 Activities Report and Appendix 4C: Platform Integration Nears Completion, Revenue Growth Exceeds Projections, and Strategic Partnerships Expand

Careteq’s FY25 Interim Results Presentation: Maiden EBITDA profit achieved ahead of target

Careteq is pleased to release its FY25 Interim Results Presentation.

Careteq’s 1H FY25 Results: Maiden EBITDA profit achieved ahead of target

Careteq’s 1H FY25 Results show Maiden EBITDA profit achieved ahead of target

Careteq Announces Strategic Partnership with Medic Alert

MedicAlert Foundation and Careteq Announce Strategic Partnership to Enhance Medication Safety for Australians.

Careteq’s AGM Presentation 2024

Careteq Limited (ASX: CTQ, “Careteq” or the “Group”), is pleased to release its 2024 AGM Presentation.

Careteq’s Annual Report 2024

Careteq Limited (ASX: CTQ, “Careteq” or the “Group”), is pleased to release its 2024 Annual Report.

Investor Enquiries

  • This field is for validation purposes and should be left unchanged.